Skip to main content
Top

Familial Cancer

Issue 2/2019

Content (20 Articles)

Original Article

Development and pilot testing of a leaflet informing women with breast cancer about genomic testing for polygenic risk

Rajneesh Kaur, Bettina Meiser, Tatiane Yanes, Mary-Anne Young, Kristine Barlow-Stewart, Tony Roscioli, Sian Smith, Paul A. James

Original Article

Electronically ascertained extended pedigrees in breast cancer genetic counseling

V. Stefansdottir, H. Skirton, O. Th. Johannsson, H. Olafsdottir, G. H. Olafsdottir, L. Tryggvadottir, J. J. Jonsson

Letter to the Editor

Ovarian small cell carcinoma in one of a pair of monozygous twins

Somayyeh Fahiminiya, Nelly Sabbaghian, Steffen Albrecht, Javad Nadaf, Donato Callegaro-Filho, William D. Foulkes

Original Article

Massive juvenile polyposis of the stomach in a family with SMAD4 gene mutation

Maurizio Ponz de Leon, Monica Pedroni, Alessandra Viel, Claudio Luppi, Rita Conigliaro, Federica Domati, Giuseppina Rossi, Luca Reggiani Bonetti

Short Communication

Germline mutation p.N363K in POLE is associated with an increased risk of colorectal cancer and giant cell glioblastoma

P. Vande Perre, A. Siegfried, C. Corsini, D. Bonnet, C. Toulas, N. Hamzaoui, J. Selves, E. Chipoulet, J. S. Hoffmann, E. Uro-Coste, R. Guimbaud

Basalioma Short Communication

NTHL1-associate polyposis: first Australian case report

Alexandra Groves, Margaret Gleeson, Allan D. Spigelman

Original Article

Risk of multiple colorectal cancer development depends on age and subgroup in individuals with hereditary predisposition

Lars J. Lindberg, Wia Wegen-Haitsma, Steen Ladelund, Lars Smith-Hansen, Christina Therkildsen, Inge Bernstein, Mef Nilbert

Short Communication

A squamous cell carcinoma in a young woman with Lynch syndrome

F. Adan, M. B. Crijns, E. Dekker, B. A. J. Bastiaansen, O. Lapid, P. Snaebjornsson, E. H. Rosenberg, M. E. van Leerdam, M. W. Bekkenk

Original Article

Monoallelic MUTYH carrier status is not associated with increased breast cancer risk in a multigene panel cohort

Kelly Fulk, Holly LaDuca, Mary Helen Black, Dajun Qian, Yuan Tian, Amal Yussuf, Carin Espenschied, Kory Jasperson

Multi-gene panel testing confirms phenotypic variability in MUTYH-Associated Polyposis

Erin G. Sutcliffe, Amanda Bartenbaker Thompson, Amy R. Stettner, Megan L. Marshall, Maegan E. Roberts, Lisa R. Susswein, Ying Wang, Rachel T. Klein, Kathleen S. Hruska, Benjamin D. Solomon

Recent advances in Lynch syndrome

Leah H. Biller, Sapna Syngal, Matthew B. Yurgelun

Original Article

Interest in, willingness-to-pay for and willingness-to-recommend genetic testing for prostate cancer among affected men after radical prostatectomy

Marcel Mayer, Katharina Selig, Frank Tüttelmann, Andreas Dinkel, Jürgen E. Gschwend, Kathleen Herkommer

Open Access Original Article

Genetic counselling of young women with breast cancer for Li–Fraumeni syndrome: a nationwide survey on the experiences and attitudes of genetics professionals

J. J. Bakhuizen, M. E. Velthuizen, S. Stehouwer, E. M. Bleiker, M. G. Ausems

Original Article

Referral frequency, attrition rate, and outcomes of germline testing in patients with pancreatic adenocarcinoma

Evan J. Walker, Julia Carnevale, Christina Pedley, Amie Blanco, Salina Chan, Eric A. Collisson, Margaret A. Tempero, Andrew H. Ko

Original Article

Cleft lip/palate and hereditary diffuse gastric cancer: report of a family harboring a CDH1 c.687 + 1G > A germline mutation and review of the literature

Florian Obermair, Melanie Rammer, Jonathan Burghofer, Theodora Malli, Anna Schossig, Katharina Wimmer, Wolfgang Kranewitter, Beate Mayrbaeurl, Hans-Christoph Duba, Gerald Webersinke

Short Communication

Hereditary brain tumor with a homozygous germline mutation in PMS2: pedigree analysis and prenatal screening in a family with constitutional mismatch repair deficiency (CMMRD) syndrome

Shahid Mahmood Baig, Ambrin Fatima, Muhammad Tariq, Tahir Naeem Khan, Zafar Ali, Mohammad Faheem, Humera Mahmood, Patrick Killela, Matthew Waitkus, Yiping He, Fangping Zhao, Sizhen Wang, Yuchen Jiao, Hai Yan

Breast Cancer Original Article

TP53 germline mutation testing in early-onset breast cancer: findings from a nationwide cohort

J. J. Bakhuizen, F. B. Hogervorst, M. E. Velthuizen, M. W. Ruijs, K. van Engelen, T. A. van Os, J. J. Gille, M. Collée, A. M. van den Ouweland, C. J. van Asperen, C. M. Kets, A. R. Mensenkamp, E. M. Leter, M. J. Blok, M. M. de Jong, M. G. Ausems

Open Access Short Communication

Boosting care and knowledge about hereditary cancer: European Reference Network on Genetic Tumour Risk Syndromes

Janet R. Vos, Lisette Giepmans, Claas Röhl, Nicoline Geverink, Nicoline Hoogerbrugge, Nicoline Hoogerbrugge, Marjolijn Ligtenberg, Marleen Kets, Rolf Sijmons, Gareth Evans, Emma Woodward, Marc Tischkowitz, Eamonn Maher, Verena Steinke-Lange, Elke Holinski-Feder, Thierry Frebourg, Claude Houdayer, Rosalie E. Ferner, Jan Lubinski, Karolina Ertmanska, Svetlana Bajalica Lagercrantz, Emma Tham, Ignacio Blanco Guillermo, Gabriel Capella, Joan Brunet Vidal, Conxi Lázaro, Judith Balmaña, Vincent Bours, Eric Legius, Pierre Wolkenstein, Bela Melegh, Carla Oliveira, Manuel Teixeira, Bruce Poppe, Kathleen Claes, Hector Salvador Hernandez, Stefan Aretz, Isabel Spier, Rianne Oostenbrink, Mateja Krajc, Ana Blatnik, Evelin Schröck, Sirkku Peltonen, Marja Hietala, Chrystelle Colas

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine